Target intelligence / Profile preview

Novel transcript, sense intronic to CNTN4 (ENSG00000286363)

Target
ENSG00000286363
Molecular classification
Other (non-coding RNA transcript)
01

Overview

ENSG00000286363 is annotated as a "novel transcript, sense intronic to CNTN4," referring to a non-protein-coding RNA (ncRNA) located within an intron of the **CNTN4** gene, in the same orientation as CNTN4[1]. This transcript does not represent a canonical protein, receptor, enzyme, or well-characterized regulatory RNA. There is currently no functional, disease, or therapeutic annotation for ENSG00000286363, and it is not listed as a target for drug development, biomarker selection, or other biomedical uses. Its presence in genomic databases reflects transcriptomic mapping and not functional importance[1]. Key clarifications: - This entry is *not* the protein-coding gene **Contactin-4 (CNTN4)**, which is a neuronal cell adhesion molecule implicated in neurodevelopment and associated disorders, not this transcript[1][3][5][7]. - ENSG00000286363 should not be considered a therapeutic target nor associated with clinical pharmacology or drug–target interaction. - If a "target" refers to molecules with pharmacological, therapeutic, or clinical biomarker roles, then this transcript is not a valid entry and "is_incorrect" should be set to true.

Other names
ENSG00000286363novel intronic transcript in CNTN4
02

Mechanism of action

None applicable; no therapeutically actionable mechanism

03

Biological functions

UnknownNot established as functionalLacks experimental evidence of a biological role
04

Disease associations

None specifically attributed to this transcriptNo evidence for direct disease association

Beyond the preview

Go deeper on Novel transcript, sense intronic to CNTN4 (ENSG00000286363).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, sense intronic to CNTN4 (ENSG00000286363).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call